Genetic polymorphism in postoperative sepsis after open heart surgery in infants

Asian Cardiovascular and Thoracic Annals

Volumn 24, Issue 4, 2016, Pages 326-331

  Fakhri, Dicky ^a   Djauzi, Samsuridjal ^b   Murni, Tri Wahyu ^c   Rachmat, Jusuf ^b   Harahap, Alida Roswita ^b   Rahayuningsih, Sri Endah ^c   Mansyur, Muchtaruddin ^b   Santoso, Anwar ^a  

^a NATIONAL CARDIOVASCULAR CENTER HARAPAN KITA   (Indonesia)

^b UNIVERSITY OF INDONESIA   (Indonesia)

^c PADJADJARAN UNIVERSITY   (Indonesia)

Author keywords

Genetic predisposition to disease; human; Immune system; Infant; Sepsis; Toll like receptor 2; TOLLIP protein

Indexed keywords

PROTEIN; TOLL INTERACTING PROTEIN; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; SIGNAL PEPTIDE; TLR2 PROTEIN, HUMAN; TOLLIP PROTEIN, HUMAN;

ARTICLE; CARDIOPULMONARY BYPASS; COHORT ANALYSIS; DISEASE COURSE; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INFANT; INFANT DISEASE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NEWBORN; NUTRITIONAL STATUS; OPEN HEART SURGERY; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN POLYMORPHISM; SEPSIS; ADVERSE EFFECTS; AGE; CHI SQUARE DISTRIBUTION; GENETIC ASSOCIATION STUDY; GENETICS; HEART SURGERY; IMMUNOLOGY; ODDS RATIO; PHENOTYPE; PROTECTION; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME;

AGE FACTORS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CHI-SQUARE DISTRIBUTION; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; PROTECTIVE FACTORS; RISK ASSESSMENT; RISK FACTORS; SEPSIS; TOLL-LIKE RECEPTOR 2; TREATMENT OUTCOME;

EID: 84963995288     PISSN: 02184923     EISSN: 18165370     Source Type: Journal    
DOI: 10.1177/0218492316640128     Document Type: Article

References (13)

1. Barker GM, O'Brien SM, Welke KF, et al. Major infection after pediatric cardiac surgery: a risk estimation model. Ann Thorac Surg 2010; 89: 843-850.
2. Wheeler DS, Jeffries HE, Zimmerman JJ, Wong HR, Carcillo JA,. Sepsis in the pediatric cardiac intensive care unit. World J Pediatr Congenit Heart Surg 2011; 2: 393-399.
3. Tárnok A, Schneider P,. Pediatric cardiac surgery with cardiopulmonary bypass: pathways contributing to transient systemic immune suppression [review]. Shock 2001; 16: 24-32.
4. Iyer SS, Chatraw JH, Tan WG, et al. Protein energy malnutrition impairs homeostatic proliferation of memory CD8 T cells. J Immunol 2012; 188: 77-84.
5. Wynn J, Cornell TT, Wong HR, Shanley TP, Wheeler DS,. The host response to sepsis and developmental impact [review]. Pediatrics 2010; 125: 1031-1041.
6. Levy O,. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007; 7: 379-390.
7. Texereau J, Chiche JD, Taylor W, Choukroun G, Comba B, Mira JP,. The importance of toll-like receptor polymorphisms in severe infections. Clin Infect Dis 2005; 41 (Suppl 7): S408-S415.
8. Burns K, Clatworthy J, Martin L, et al. Tollip, a new component of the IL-1RI, links IRAK to the IL-1 receptor. Nat Cell Biol 2000; 2: 346-351.
9. Abu-Maziad A, Schaa K, Bell EF, et al. Role of polymorphic variants as genetic modulators of infection in neonatal sepsis. Pediatr Res 2010; 68: 323-329.
10. Song Z, Yin J, Sun Z, et al. Variants in the toll-interacting protein gene are associated with susceptibility to sepsis in the Chinese Han population. Crit Care 2011; 15: R12-R12.
11. Dellinger RH, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM,. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41: 580-637.
12. Franke A, Lante W, Fackeldey Y, et al. Proinflammatory and antiinflammatory cytokines after cardiac operation: different cellular sources at different times. Ann Thorac Surg 2002; 74: 363-370.
13. World Health Organization: Department of Communicable Disease, Surveillance and Response. Prevention of hospital-acquired infections: a practical guide. 2nd Edition. Available at: www.who.int/csr/resources/publications/drugresist/WHO-CDS-CSR-EPH-2002-12/en. Accessed February 11, 2016.